YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report)’s stock price traded up 1.3% on Thursday . The company traded as high as $16.15 and last traded at $16.07. 129,295 shares changed hands during trading, a decline of 39% from the average session volume of 212,895 shares. The stock had previously closed at $15.86.
YieldMax MRNA Option Income Strategy ETF Trading Up 1.3%
The business’s 50-day simple moving average is $17.03 and its two-hundred day simple moving average is $17.38.
YieldMax MRNA Option Income Strategy ETF Company Profile
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
Read More
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
